SELLAS Receives Orphan Medicinal Product Designation Approval by the Committee for Orphan Medicinal Products of the European Medicines Agency Biotech Investing
VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals Biotech Investing
Asterias Provides 24 Month Cohort 2 Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury Biotech Investing
Shire Granted EU Marketing Authorization for Veyvondi for Adults With Von Willebrand Disease Biotech Investing
Vital Therapies Announces That Topline Results of VTL-308 Fail to Achieve Primary and Secondary Endpoints of Improvement in Survival Biotech Investing
Phivida Introduces Premium Active Hemp Extract Infused Functional Beverage and Supplement Line to Mainstream Retailers in the U.S. Cannabis Investing News
IMV Announces Phase 2 Basket Trial in Collaboration with Merck to Evaluate DPX-Survivac in Combination with KEYTRUDA Across Five Solid Tumor Indications Biotech Investing
